Insiders · Profile

Mitchener Stephen

SVP, Chief Business Officer at Karyopharm Therapeutics. Filing since 2 Jun 2021. CIK 0001774519

Company
Date
Role
Action
Shares
Amount
Of holding
1 Mar 2023
SVP, Chief Business Officer
Sold, plan not stated
6,357
$19.26K
4.7%
2 Dec 2021
SVP, Chief Business Officer
Sold, plan not stated
499
$3.34K
13.1%
2 Jun 2021
SVP, Chief Business Officer
Sold, plan not stated
528
$4.91K
17.6%
3 decisions on file.